chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Gave me the vaccine and I got them/ Suspected vaccination failure; Got them under my breasts; Terrible burning, cant wear bra; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and burning sensation. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles and burning sensation were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and burning sensation to be related to Shingles vaccine.     Additional Information: GSK receipt date: 02-DEC-2022 Reporter's comment:  This case was reported by a consumer via interactive digital media. The patient reported that she had with them under her breasts for 2 months and she could not wear bra. A terrible burning and they gave her the vaccine and she got them. The patient said If she was known, she did not put it on, but it was optional. They gave her the vaccine for that disgusting thing of shingles and now patient had 2 months that they did not go away with anything and she had some terrible burning. Additional supportive information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. Follow up would not possible, as no contact details were available.
cried almost cont x 48hr a/calming for any period of time;devel change in bowel movements x 8 days then returned to more nl;devel macular rash over trunk & extremities 1wk p/vax;fever never excessive;inc flatus
5 years of child was given Shingrix; This case was reported by a consumer via interactive digital media and described the occurrence of inappropriate age at vaccine administration in a 5-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.  Additional Information: GSK Receipt Date: 05-Aug-2022. Reporter's Comments: This case was reported by the parent of the patient via  interactive digital media. The 5 years old patient received Shingrix in error. Additional Supportive Information: The 5 years old patient received Shingrix in error, which led to inappropriate age at vaccine administration. The follow-up would not possible as no contact details were available.
thought about suicide; Severe Depression after both doses; This is a spontaneous report received from a contactable consumer, the patient. A 45-year-old [non-pregnant] adult female received COVID-19 immunization with the first dose of intramuscular BNT162B2 (solution for injection; batch/lot and expiry information not provided) as single dose in the left arm on 08Mar2021 at 08:00 (at 44-years-old); and the second dose of intramuscular BNT162B2 (solution for injection; batch/lot and expiry information not provided) as single dose in the right arm on 07Apr2021 at 10:45 (at 44-years-old). Relevant medical history included high blood pressure and penicillin allergy. Concomitant medications sans indication, posology and therapy dates included amlodipine; benazepril; and nebivolol hydrochloride (BYSTOLIC). The patient was not pregnant at the time of vaccination. The patient denied receiving any other vaccine within four weeks prior to this vaccine. The patient reported that she experienced severe depression after both doses. The patient explained that on an unspecified date in Mar2021, reported as about three days after the first dose of the vaccine, the patient experienced severe depression. The patient reported that on 07Apr2021, around eight hours after the second dose of the vaccine, the patient experienced severe depression. The patient reported that she thought about suicide as well. There was no treatment received. The outcome of the events severe depression and thought about suicide was not recovered.    The lot number for the vaccine BNT162B2 was not provided and will be requested during follow up.
Losing consciousness; Dizziness; Vomiting; Nausea; A spontaneous report was received from a consumer, who was also a female patient, who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced nausea, vomiting, dizziness, and losing consciousness.   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On 18 Jan 2021, approximately one day prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.    On 18 Jan 2021, the patient reported having nausea and vomiting all night. Additionally, she also experienced dizziness and losing consciousness. Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was unknown.   The outcome of the events nausea, vomiting, dizziness, and losing consciousness was unknown.; Reporter's Comments: This spontaneous report concerns a female patient who experienced a serious event of losing consciousness and non-serious events of nausea and vomiting. The events occurred on the same day after the administration of the first dose of the vaccine mRNA-1273 vaccine (Lot #: Unknown, expiration date-Unknown).  No treatment was reported, and outcome is unknown.  Based on the information provided, which includes a strong temporal association between the reported events and the administration of mRNA-1273 vaccine, a causal association cannot be excluded. Nausea and vomiting are consistent with the known safety profile of mRNA-1273 vaccine.
DTaP on wednesday 4/30 and Friday May 2nd Fever started about 6 that was noticable temp read 102.7 and a dose of motrin was given and then tylenol ater one hour when the fever was still 102 and then about 15-20 after last dose fever seizure started ans last for about 1.5 min of convulsions and then a few min of dazed stare. called 911 during the episode and ambulance and fire department arrived to take him directly to hospital.
Sore arms, fever, unable to sleep.  The symptoms started about 10 hours after vaccinations.  Fever was 101.7 about 20 hours after vaccinations.  Ibuprofen and rest for about 8 hours and all symptoms were gone except sore arms.
nerve pain; was vaccinated and came down with shingles / suspected vaccination failure; came down with shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. In May 2021, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the patient experienced nerve pain. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was recovered/resolved and the outcome of the nerve pain was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and nerve pain to be related to Shingles vaccine.  Additional case details were reported as follows: The reporter was patient's wife. The age at vaccination was not reported. The patient was vaccinated and came down with shingles this past May. The shingles were gone but he was still dealing with the nerve pain months later. The patient stated that this vaccine did not guarantee that you would not get shingles. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required
Bilateral red thighs, induration, warm, very red 24 hours post immunizations. Tx Atarax syrup tsp q 6 hrs prn, Tylenol liquid 1 1/2 tsp q 4-6 hours prn, Prelone tsp bid x 4 days (15mg/5ml)
Blister all over tongue; This spontaneous case was reported by a consumer and describes the occurrence of ORAL MUCOSAL BLISTERING (Blister all over tongue) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced ORAL MUCOSAL BLISTERING (Blister all over tongue). At the time of the report, ORAL MUCOSAL BLISTERING (Blister all over tongue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details included None.   Reporter did not allow further contact
Febrile seizure, 2 weeks after injections admitted to hospital x 4 days. No other cause found for fever.
Weakness and lost of strength of both upper legs or thighs Started with high fever, chills, headache and now even 3 weeks later have lost strength in legs and right arm
Fever of 101.4 for 48 hours, chills, muscle aches, headache, nausea. Stayed in bed for 3 days
Severe heart elevation of  160 (  at 3am on 12.10.2021) less than 24hrs after vaccine administration.  Loss of taste.  Difficulty walking due muscle weakness in leg.  Did not seek medical treatment for above.  12/12/2021 medical treatment  at local ER  sought for heart palpitations even though heart rhythm was regular.  12/13/2021 at 5am awaken out of sleep, heart rate increased to 158, pounding. Taken to local ER evaluation and was told heart elevation most likely caused /related to vaccine.
Immediately upon injection patients arm swelled up and welted. She started flushing and said she felt as if an allergic reaction was coming on. Patient took diphenhydramine then waited around for about 45 minutes. During that time period she stated that she was feeling much better. She stated that when injected she felt vaccine go into her arm then "up her neck and head" and she said she felt a hot rush with it go into her chest.
Aches, chills, diarrhea next day and into following week. Congestion URI 4d later, still achy z 1 1/2wks.
Next day after 2nd dose of Moderna vaccine: Fever, chills, malaise, arm pain for one day - took Ibuprofen  Better following day.
Developed rash 11/17 on arms, hands, legs & face. Took Actifed & OTC cream. Seen in SHS 11/20. No visible rash seen in SHS.
Headaches; Stomach aches; felt lightheaded; he was injected, with the adjuvant suspension only; he was injected, with the adjuvant suspension only; This case was reported by a consumer via call center representative and described the occurrence of headache in a 61-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In June 2021, the patient received the 1st dose of Shingrix. In June 2021, less than a week after receiving Shingrix, the patient experienced headache, stomach pain, light headedness, inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the headache, stomach pain and light headedness were not recovered/not resolved and the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   It was unknown if the reporter considered the headache, stomach pain and light headedness to be related to Shingrix.  Additional details were provided as follows: The case was reported by the patient. The patient received the first dose of shingrix one week ago of the reporting date. The patient stated that, after receiving the shot he developed headaches, stomach aches and felt lightheaded.  On 9th June 2021, his health care professional reached out to him to inform him that he was injected, with the adjuvant suspension only, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The patient stated that, the symptoms did not resolve. The reporter consented to follow up
Patient had redness and itching at injection site. Patient applied ice but was unwilling to apply or take any medication.
Patient hospitalized within a month of receiving J&J vaccine (symptom onset reported two days after administration) INCARCERATED VENTRAL HERNIA; SMALL BOWEL OBSTRUCTION Received COVID vaccine (J&J) - 1.7.22 Symptoms started - 1.9.22 (diarrhea, body-aches, fatigue, vomiting, pain in stomach, wheezing)  - reported 1.18.22 Seen by PCP (1.19.22) - Fatigue, diarrhea, vomiting 1.9.22; body-aches, sneezing, no exposures - ill, nauseous, queasy, achy, miss work - DX: URI, obtain CXR (-), and COVID/flu swab (-).  started doxycycline for 'sinusitis'; prescribed zofran; albuterol for wheeze.  Labs - mild increase WBC, not peeing as much - abnormal CMP (SCR increased from 0.82 in 2018 - to 2.65; potassium 5.1; BUN 98; eGFR 25; triglycerides 229; hgb A1c - 7.1; glucose 143; BNP normal) 1.26.22 - PCP office visit - diagnosed with diabetes mellitus - -will start on metformin 500 mg bid (reviewed this may cause diarrhea) -monofilament and urine microalbumin completed for 2022 -positive for urine microalbumin but will hold off on restarting lisinopril at this time due to renal insufficiency -will re-evaluate if renal function is improving -will refer to diabetes education -will refer for diabetic eye exam -reviewed long term complications of uncontrolled diabetes including kidney failure, blindness, heart attack, and stroke -follow up in 3 months 2.4.22 - Office visit - PCP - abdominal pain. (reported to Nurse Triage on 2.3.22 - continued diarrhea, vomiting, has been seen multiple times; now on inhaler and meds for DM; wheezing; significant abdominal pain)  Hospitalized 2.7.22: Assessment & Plan: 60 y/o M with ventral incarcerated hernia. Given tenderness and obstruction, we are obligated to explore his abdomen.   HPI: Patient is a 60 y.o. male with history of primary UHR in 2018 for incarcerated hernia, EtOH abuse, HTN, and T2DM who presents today with one week of obstructive symptoms related to his ventral hernia. He says starting one week ago he noticed an abdominal bulge that was painful and with associated nausea and emesis. He also endorses belching. His last BM was this morning but was very small. He has not passed flatus in several days. He says he has been "living on slimfast, powerades."   Progress Note from 2.10.22:  ASSESSMENT / PLAN:  Assessment: Patient is a 60 y.o. male with  history significant for UHR who presents with incarcerated ventral hernia and associated SBO and is now s/p ventral hernia repair with JP placement in subQ space 2/8/22.   Plan: SBO 2/2 ventral hernia - S/p open repair of hernia in OR 2/8 - Diet: CLD, tolerating. Advance to general - Keep JP drain for now. Will pull once < 30 cc for two consecutive days. - NGT self-pulled 2/9 x2 - Analgesic regimen: sch tylenol/robaxin, prn oxy              - denied TAP blocks - Antiemetic regimen: PRN IV Zofran, PRN Compazine - Will initiate gentle bowel regimen
Woke-up with a rash; This case was reported by a consumer via call center representative and described the occurrence of rash in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (several previous cases of shingles prior to 14th April 2021).   On 14th April 2021, the patient received the 1st dose of Shingrix (intramuscular). On 27th August 2021, 135 days after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was not recovered/not resolved.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were provided as follows: The case was reported by the patient for herself. The patient reported that, she received her first Shingrix vaccine in the left arm.  The patient woke-up with a rash on her right ear lobe and believed it was shingles.  The patient reported that, she had several previous cases of shingles prior to 14th April 2021 and was pretty sure this rash is leading to another case of shingles.  The reporter referred to health care professional. The patient was scheduled to receive her second Shingrix vaccine on the day of reporting.. The reporter did not consent to follow-up. The reporter did not gave permission to contact health care professional.
severe fatigue, muscle & joint pain, sleep disorder, short term memory loss, short attention span, weight gain NOV98;pt exp local irritation p/shot;
Pt <7 yrs old given Tdap instead of DTaP at time of visit at clinic on 7-25-13. No adverse effects. Pt notified of error.
87-year-old male with history of chronic systolic heart failure and atrial flutter as well as significant renal dysfunction presented to facility seen hospital with increasing shortness of breath and cough.  The patient had completed his COVID-19 vaccination but his wife had elected not to be vaccinated she evidently had contracted COVID-19 pneumonia and the patient likely obtain his infection due to close contact with her.  He predominantly noted increased weakness and shortness of breath at the time of admission.  He did require initially 2 L of supplemental oxygen which was relatively quickly weaned off over his 2nd hospital day.   The patient was placed on remdesivir and dexamethasone for treatment of his COVID-19 pneumonia.  He steadily improved over the course of his hospital stay
HOSPITAL CALLED TO INFORM US THAT THE PATIENT HAD BEEN ADMITTED DUE TO REACTION TO A VACCINE. WHEN INQUIRING WHAT HAPPENED THE NURSE STATED THAT THEY THINK THE INJECTION HAD BEEN GIVEN INTO THE GLENOHUMERAL JOINT.
Information has been received from a Medical assistant concerning a multiple unspecified number of patients (ages and genders not reported) who on unknown dates were vaccinated with improperly stored doses of GARDASIL 9 (Batch and Lot No. L020015, exp. 16-AUG-2017) (dose, site and route not reported). No adverse effects were reported. This report is linked to MARRS 1601USA000936, 1601USA001941, 1601USA001942, 1601USA001943 and 1601USA001944. Additional information had been requested.
I had my vaccination on 12/18/2021. On 11/04/2022 I started to experience a sore throat and a cough. I tested COVID-19 positive on 11/05/2022 at home. I tested COVID-19 positive on 11/06/2022 at the walk-in clinic. I was not prescribed any medication.
Information has been received from a physician assistant concerning a 20 year old white female student patient who on 25-JUL-2008 was vaccinated with the first dose of GARDASIL vaccine (yeast) (lot # 660555/0279X) IM in her right arm. Concomitant therapy included YAZ. On 26-JUL-2008, the patient experienced shortness of breath, pain in back lung area with deep breath, rash on lower extremities, after administration of her first dose of GARDASIL vaccine. The patient recovered from shortness of breath, pain upon deep breaths and rash, in less than 48 hours. No further information is available.
Pfizer-BioNTech COVID-19 Vaccine EUA: nine and eleven days after vaccination during clinic visit patient reports left axillary swelling radiating down left arm. Subsequently developed numbness and tingling to left hand/fingers seven days after vaccination.  Arthralgias, joint swelling, mylagias, and weakness also noted. After first visit patient prescribed methylprednisolone. Two days later patient returned to clinic with improvement in swelling but reports tremors and three new bumps on arm, palpitations, and weakness/numbness of 4th and 5th digits on left hand proximally. Patient referred to neurology and physical therapy with diagnosis of ulnar neuropathy.
child awaken with swollen, hot to the touch upper Lt arm. Swelling in circum. around upper arm with skin swelling; elbow to shoulder swelling. Rx. Zyrtec syrup 1/2 tsp q day x 3-4 days.
Tachycardia, cold, clamy, generalized itching, chattering of teeth 2.5 hours after administering Fluarix.
she couldn't walk because she ached all over; she couldn't walk because she ached all over; Her neck hurt; Her eyes hurt; She couldn't stand up; She thought she was dying; She got sick; She felt rubbery; This is a spontaneous report from a contactable consumer(patient). An unspecified age female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 15Feb2021 at 09:00 as a single dose for COVID-19 immunization. The patient had received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unknown date Feb2021, the patient felt rubbery. On 16Feb2021, the patient experienced couldn't walk because she ached all over, Her neck hurt, Her eyes hurt, couldn't stand up, thought she was dying, got sick. It was reported that Caller received her 2nd dose of the Pfizer covid vaccine on Monday at 9:00 AM. She got sick and was aching all over. Her eyes and neck hurt to the point that she could not walk or stand up. Caller states her grandson had to help her get to bed. She 'felt rubbery'. She went to (hospital name_ and got her second shot. The next day she couldn't walk because she ached all over. Her neck hurt. Her eyes hurt. She couldn't stand up. She thought she was dying.  What can she do to straighten it out? She had no trouble with the first shot. Caller clarified shot as COVID19 Vaccine. She called her family doctor and the doctor said she needed to call #. Caller dialed # and the gal that she talked to said that she need to call #. Caller states she doesn't want to go to the hospital. Is there anything she can get to take? Her doctor said she wouldn't touch it.  She wants to talk to someone. She feels a little better today. Will it take a while to get out of her? Caller declined to do a report. She got the second shot on Monday, 15Feb2021, in the morning at 9AM. Tuesday was when she got sick. She ached all over. Description of complaint: She got her second shot. The next day she couldn't walk because she ached all over. Her neck hurt. Her eyes hurt. She couldn't stand up. She thought she was dying. She had no trouble with the first shot. Caller clarified shot as COVID19 Vaccine. Her doctor said she wouldn't touch it. Will it take a while to get out of her? Caller declined to do a report. The outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot been obtained
The patient was given the Influenza and GARDASIL vaccines around 4:00 PM. Later that night (approximately 10:30 PM) she called the on call service saying she had muscle pain, shivers and throat tightness. By the time the physician called here back (10:40 PM) her symptoms had resolved. She took TYLENOL
Pt had PREVNAR 13 adm to left arm. Pt reported fever and chills all night. Pt didn't check temp; no temperature today.